# Surrozen, Inc.: filings

SRZN · Nasdaq · CIK 1824893 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/srzn.md) · [Financials](/companies/srzn/financials.md) · [Filings](/companies/srzn/filings.md) · [Insiders](/companies/srzn/insiders.md)

## Reports and events: 114 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 144, 8-K 59, 424B3 29, 3 27, SCHEDULE 13G/A 26, CORRESP 19, 10-Q 18, SCHEDULE 13G 14, EFFECT 12, SC 13G 12, 425 10, 4/A 10, SC 13G/A 10, 3/A 8, UPLOAD 8, 424B5 7, S-8 7, SC 13D/A 7, 10-K 6, DEF 14A 6, DEFA14A 6, S-1/A 6, S-3 5, ARS 4, SCHEDULE 13D/A 4, CERT 3, POS AM 3, S-1 3, 10-K/A 2, 8-A12B 2, D 2, S-4/A 2, SC 13D 2, 10-Q/A 1, 25 1, 25-NSE 1, 424B4 1, 8-A12B/A 1, DEFM14A 1, DRS 1, NT 10-K 1, NT 10-Q 1, PRE 14A 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 20:45 ET | [SCHEDULE 13D/A](/filings/0001193125-26-429027.md) | Ownership report, active investor, amended | 0001193125-26-429027 |
| 2026-10-20 | 21:04 ET | [8-K](/filings/0001193125-26-426828.md) | 2.02 Results of operations; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-426828 |
| 2026-10-02 | 12:05 ET | [8-K](/filings/0001193125-26-411298.md) | 8.01 Other events | 0001193125-26-411298 |
| 2026-08-06 | 20:23 ET | [10-Q](/filings/0001193125-26-338120.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338120 |
| 2026-08-06 | 20:15 ET | [8-K](/filings/0001193125-26-338068.md) | 2.02 Results of operations | 0001193125-26-338068 |
| 2026-05-18 | 10:49 ET | [SCHEDULE 13D/A](/filings/0001193125-26-227857.md) | Ownership report, active investor, amended | 0001193125-26-227857 |
| 2026-05-14 | 20:13 ET | [8-K](/filings/0001193125-26-224037.md) | 5.07 Shareholder vote results | 0001193125-26-224037 |
| 2026-05-06 | 20:38 ET | [10-Q](/filings/0001193125-26-209179.md) | Quarterly report, period 2026-03-31 | 0001193125-26-209179 |
| 2026-05-06 | 20:15 ET | [8-K](/filings/0001193125-26-208999.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-208999 |
| 2026-04-01 | 20:23 ET | [DEF 14A](/filings/0001193125-26-137976.md) | Proxy statement, period 2026-04-01 | 0001193125-26-137976 |
| 2026-03-23 | 20:30 ET | [10-K](/filings/0001193125-26-119818.md) | Annual report, period 2025-12-31 | 0001193125-26-119818 |
| 2026-03-23 | 20:16 ET | [8-K](/filings/0001193125-26-119757.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-119757 |
| 2026-01-30 | 21:08 ET | [8-K](/filings/0001193125-26-031798.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-031798 |
| 2026-01-22 | 23:55 ET | [SCHEDULE 13D/A](/filings/0001193125-26-019817.md) | Ownership report, active investor, amended | 0001193125-26-019817 |
| 2025-11-07 | 21:24 ET | [10-Q](/filings/0001193125-25-272422.md) | Quarterly report, period 2025-09-30 | 0001193125-25-272422 |
| 2025-11-07 | 21:11 ET | [8-K](/filings/0001193125-25-272363.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors | 0001193125-25-272363 |
| 2025-10-17 | 20:14 ET | [8-K](/filings/0001193125-25-242518.md) | 1.02 Termination of a material agreement | 0001193125-25-242518 |
| 2025-08-29 | 20:58 ET | [8-K](/filings/0000950170-25-112253.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-112253 |
| 2025-08-08 | 20:14 ET | [10-Q](/filings/0000950170-25-105847.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105847 |
| 2025-08-08 | 20:12 ET | [8-K](/filings/0000950170-25-105839.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105839 |
| 2025-05-15 | 20:22 ET | [8-K](/filings/0000950170-25-072696.md) | 5.07 Shareholder vote results | 0000950170-25-072696 |
| 2025-05-09 | 20:16 ET | [10-Q](/filings/0000950170-25-068046.md) | Quarterly report, period 2025-03-31 | 0000950170-25-068046 |
| 2025-05-09 | 20:08 ET | [8-K](/filings/0000950170-25-068011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-068011 |
| 2025-04-02 | 20:17 ET | [DEF 14A](/filings/0000950170-25-049352.md) | Proxy statement, period 2025-05-14 | 0000950170-25-049352 |
| 2025-03-31 | 20:12 ET | [10-K](/filings/0000950170-25-047712.md) | Annual report, period 2024-12-31 | 0000950170-25-047712 |
| 2025-03-31 | 20:07 ET | [8-K](/filings/0000950170-25-047702.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-047702 |
| 2025-03-28 | 01:19 ET | [SCHEDULE 13D/A](/filings/0000950170-25-047114.md) | Ownership report, active investor, amended | 0000950170-25-047114 |
| 2025-03-28 | 20:08 ET | [8-K](/filings/0000950170-25-046769.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-046769 |
| 2025-03-24 | 20:11 ET | [8-K](/filings/0001193125-25-061361.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-061361 |
| 2024-11-06 | 21:13 ET | [10-Q](/filings/0000950170-24-122318.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122318 |
| 2024-11-06 | 14:07 ET | [8-K](/filings/0000950170-24-121856.md) | 2.02 Results of operations | 0000950170-24-121856 |
| 2024-10-02 | 20:28 ET | [8-K](/filings/0000950170-24-111493.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-111493 |
| 2024-08-12 | 20:14 ET | [10-Q](/filings/0000950170-24-095443.md) | Quarterly report, period 2024-06-30 | 0000950170-24-095443 |
| 2024-08-12 | 20:08 ET | [8-K](/filings/0000950170-24-095414.md) | 2.02 Results of operations | 0000950170-24-095414 |
| 2024-07-01 | 20:41 ET | [8-K](/filings/0000950170-24-079690.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-079690 |
| 2024-06-07 | 20:35 ET | [8-K](/filings/0000950170-24-070741.md) | 5.07 Shareholder vote results | 0000950170-24-070741 |
| 2024-05-08 | 20:18 ET | [10-Q](/filings/0000950170-24-055706.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055706 |
| 2024-05-08 | 20:12 ET | [8-K](/filings/0000950170-24-055667.md) | 2.02 Results of operations | 0000950170-24-055667 |
| 2024-04-23 | 20:25 ET | [DEF 14A](/filings/0000950170-24-046931.md) | Proxy statement, period 2024-06-05 | 0000950170-24-046931 |
| 2024-04-17 | 20:10 ET | [SC 13D/A](/filings/0001193125-24-099085.md) | Ownership report, active investor, amended | 0001193125-24-099085 |
| 2024-04-10 | 20:38 ET | [10-K](/filings/0000950170-24-043399.md) | Annual report, period 2023-12-31 | 0000950170-24-043399 |
| 2024-04-08 | 22:19 ET | [SC 13D/A](/filings/0001193125-24-089766.md) | Ownership report, active investor, amended | 0001193125-24-089766 |
| 2024-04-02 | 21:07 ET | [8-K](/filings/0000950170-24-040337.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-24-040337 |
| 2024-04-01 | 12:52 ET | [8-K](/filings/0000950170-24-038902.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-038902 |
| 2024-02-07 | 11:10 ET | [8-K](/filings/0000950170-24-011936.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-011936 |
| 2024-01-18 | 13:41 ET | [8-K](/filings/0000950170-24-005198.md) | 8.01 Other events | 0000950170-24-005198 |
| 2023-12-13 | 22:14 ET | [8-K](/filings/0000950170-23-070103.md) | 5.03 Amendment to articles or bylaws | 0000950170-23-070103 |
| 2023-12-11 | 21:08 ET | [8-K](/filings/0000950170-23-069405.md) | 5.07 Shareholder vote results; 8.01 Other events | 0000950170-23-069405 |
| 2023-11-08 | 21:17 ET | [10-Q](/filings/0000950170-23-061150.md) | Quarterly report, period 2023-09-30 | 0000950170-23-061150 |
| 2023-11-08 | 21:09 ET | [8-K](/filings/0000950170-23-061101.md) | 2.02 Results of operations | 0000950170-23-061101 |

Page 1 of 3. [Older](/companies/srzn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.